CLSEL vs NATHBIOGEN: Stock Comparison
CHAMAN LAL SETIA EXP is the larger company by market capitalisation. CHAMAN LAL SETIA EXP shows a higher ROE, a higher dividend yield and faster revenue growth, while NATH BIO-GENES (I) shows a lower P/E and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
CLSEL leads 7; NATHBIOGEN leads 6 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | CLSEL | NATHBIOGEN |
|---|---|---|
| Sector | Fast Moving Consumer Goods | Fast Moving Consumer Goods |
| Industry | Other Agricultural Products | Other Agricultural Products |
Price
| Metric | CLSEL | NATHBIOGEN |
|---|---|---|
| Live Price | ₹293.25 | ₹151.8 |
| Day Change | -0.56% | 3.03% |
| Volume | 19,164 | 1.1 L |
| 52-Week High | ₹324.8 | ₹204 |
| 52-Week Low | ₹203.75 | ₹126.15 |
| Distance from 52W High | -9.71% | -25.59% |
Valuation
| Metric | CLSEL | NATHBIOGEN |
|---|---|---|
| Market Cap | ₹1,462 Cr | ₹285 Cr |
| P/E Ratio | 11.57x | 8x |
| P/B Ratio | 1.73x | 0.43x |
| EPS | ₹25.18 | ₹17.18 |
| Book Value | ₹168.67 | ₹358.06 |
| Dividend Yield | 1.02% | 0% |
Growth
| Metric | CLSEL | NATHBIOGEN |
|---|---|---|
| Revenue Growth (TTM YoY) | 16.5% | -1% |
| EPS Growth (TTM YoY) | 56.2% | 0% |
| Qtr Sales Growth | -19.25% | -1.69% |
| Qtr Profit Growth | -16.41% | 1.22% |
Profitability & Leverage
| Metric | CLSEL | NATHBIOGEN |
|---|---|---|
| ROE | 13.69% | 7.75% |
| ROCE | 13.13% | 5.81% |
| Net Margin | 7.97% | 9.35% |
| Operating Margin | 11.31% | 16.54% |
| Debt to Equity | 0.1x | 0.18x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | CLSEL | NATHBIOGEN |
|---|---|---|
| Promoter Holding | 74.05% | 45.6% |
| FII Holding | 3.3%▲ 0.21 pp | 0.27%▲ 0.04 pp |
| DII Holding | 1.57%▼ 0.01 pp | 0.01% |
| Public Holding | 21.08%▼ 0.21 pp | 54.13%▼ 0.04 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: CHAMAN LAL SETIA EXP and NATH BIO-GENES (I).
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.